New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Alzamend Neuro, Inc. (ALZN) vs Cardio Diagnostics Holdings, Inc. (CDIO)
- Alzamend Neuro, Inc. ALZN 1.02 −1.92%
- Cardio Diagnostics Holdings, Inc. CDIO 1.65 −2.37%
Alzamend Neuro, Inc. and Cardio Diagnostics Holdings, Inc. are both Biotechnology companies. Alzamend Neuro, Inc. and Cardio Diagnostics Holdings, Inc. are of similar size ($4.9M and $4.9M). Alzamend Neuro, Inc. has the higher net margin (0.00% vs −42,401.3%) and the higher return on invested capital (0.00% vs −228.0%). Across the 13 metrics below, Alzamend Neuro, Inc. leads on 7 and Cardio Diagnostics Holdings, Inc. on 6.
Valuation
Profitability
| Metric | ALZN | CDIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 70.18% |
| Operating margin | 0.00% | (42,328.76%) | 0.00% |
| Net margin | 0.00% | (42,401.31%) | 0.00% |
| Free cash flow margin | 0.00% | (37,804.58%) | 0.00% |
| Return on equity | (163.23%) | (93.55%) | (51.58%) |
| Return on assets | (122.36%) | (87.24%) | (45.91%) |
| Return on invested capital | 0.00% | (227.99%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack